---
annotations:
- id: CL:0000677
  parent: native cell
  type: Cell Type Ontology
  value: gut absorptive cell
- id: PW:0001012
  parent: signaling pathway
  type: Pathway Ontology
  value: vitamin and vitamin metabolites signaling pathway
- id: DOID:11249
  parent: disease of metabolism
  type: Disease Ontology
  value: vitamin K deficiency bleeding
- id: PW:0002325
  parent: drug pathway
  type: Pathway Ontology
  value: vitamin K antagonist drug pathway
- id: CL:0000182
  parent: native cell
  type: Cell Type Ontology
  value: hepatocyte
authors:
- DeSl
- Eweitz
description: A hypothetical pathway showing the interactions of metabolites produced
  by the intestinal microbiome, which can affects the anticoagulant response of vitamin
  K antagonists (VKAs).
last-edited: 2022-12-10
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5273
- /instance/WP5273
- /instance/WP5273_r123985
revision: r123985
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5273.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: A hypothetical pathway showing the interactions of metabolites produced
    by the intestinal microbiome, which can affects the anticoagulant response of
    vitamin K antagonists (VKAs).
  keywords:
  - 1-butyrate
  - Acenocoumarol
  - Anisindione
  - Apaxiban
  - Brodifacoum
  - CD36
  - CYP2C9
  - Chlorophacinone
  - Coumatetralyl
  - Diphacinone
  - Fluindione
  - Lithocholic acid
  - NPC1L1
  - PPAR alpha
  - PPAR beta
  - PXR
  - Phenindione
  - Phenprocoumon
  - Pindone
  - SR-BI
  - Tioclomarol
  - VDR
  - Warfarin
  - dicoumarol
  - menaquinone
  - phylloquinone
  license: CC0
  name: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists
seo: CreativeWork
title: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists
wpid: WP5273
---